Bloomberg News Interview Series

Dr. Kawsar Talaat, Associate Professor of International Health at the Johns Hopkins Bloomberg School of Public Health, discusses the need for people to get the influenza and bivalent Covid vaccines.

Dr. Tom Inglesby, Director of the Johns Hopkins Center for Health Security at the Bloomberg School of Public Health, reports on the current state of Covid-19. 

Dr. Donald Warne, Co-Director of the Center for Indian Health at the Johns Hopkins Bloomberg School of Public Health, explains the health challenges facing indigenous people.

Ge Bai, Professor of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health, talks about providing assistance for underinsured healthcare patients.

Dr. Darrell Gaskin, Professor of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health, discusses working to reduce health disparities. 

Dr. Andy Pekosz, Professor of Molecular Microbiology and Immunology at Johns Hopkins University Bloomberg School of Public Health, discusses the roll out of a Covid bivalent booster.

David Dowdy, epidemiologist at the Bloomberg School, shares his thoughts on the FDA clearing the way for boosters targeting the latest COVID variants.

Frank Lin, director of the Bloomberg School's Cochlear Center for Hearing and Public Health, discusses the FDA's approval of the sale of over-the-counter hearing aids.

Cassandra Crifasi, deputy director of the Bloomberg School's Center for Gun Violence Solutions, discusses gun violence awareness and prevention. 

Joanna Cohen, director of the Institute for Global Tobacco Control at the Johns Hopkins Bloomberg School of Public Health, talks about the health effects of vaping.

Gigi Gronvall, senior scholar at the Center for Health Security, discusses the latest on monkeypox and COVID-19.
 

Tom Inglesby, director of the Johns Hopkins Center for Health Security, provides an update on COVID and monkeypox outbreaks. 
 

Eric Toner, senior scholar at the Johns Hopkins Center for Health Security at the Bloomberg School of Public Health, discusses President Biden testing positive for COVID-19 on Thursday.

David Dowdy, epidemiologist at the Johns Hopkins Bloomberg School of Public Health, shares his thoughts on the spread of the BA.5 COVID variant.

Suzanne Bell, assistant professor in the Department of Population, Family and Reproductive Health, discusses the medical community’s response to the overturning of Roe v. Wade.

Amesh Adalja, senior scholar at the Center for Health Security at the Johns Hopkins Bloomberg School of Public Health, provides an update on COVID cases.

Tamar Mendelson, director of the Center for Adolescent Health, discusses the impact of school shootings on the mental health of children.
 

Caleb Alexander, professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, discusses developing the Opioid Industry Document Archive. 

Andy Pekosz, professor of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, discusses the surge of COVID cases across the country.

Chris Beyrer, MD, provides insights on new variants of the coronavirus circulating across the globe. 
He is featured at the 38:10 mark.

Priya Duggal discusses studying the impact of Long Covid.

Len Rubenstein, director of the Bloomberg School's Program on Human Rights, Health and Conflict, talks about the vulnerability of health care in times of conflict.
 

Chris Beyrer, MD, discusses mRNA vaccine technology and benefits, as well as the sharing of these vaccines with China and other countries. 

Chris Beyrer, MD, talks about a people potentially getting a fourth Covid booster shot. 

Chris Beyrer, MD, discusses the White House efforts to get more funding for COVID research, as well as the FDA's recent authorization for a fourth vaccine dose in some populations. 

Crystal Watson, senior scholar at the Center for Health Security, shares her thoughts on the threat of Russia using biochemical weapons in their war with Ukraine.

Chris Beyrer, MD, discusses the potential ramifications of the exodus of Ukraine and the Russian invasion. 
 

Ge Bai, professor of Health Policy and Management at Johns Hopkins Bloomberg School of Public Health, discusses the impact of inflation on hospitals and public health. 

Rupali Limaye, associate scientist at the Johns Hopkins Bloomberg School of Public Health, explains why Ukraine will likely lead to an upsurge in COVID. 

Andy Pekosz, professor of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, discusses the current state of Covid and how cases are starting to wane.

Chris Beyrer, MD, says we're on the right side of the omicron surge.

Gigi Gronvall, senior scholar at the Johns Hopkins Center for Health Security, discusses some states dropping mask mandates.

Tara Kirk Sell, senior scholar at the Johns Hopkins Center for Health Security, discusses how the Beijing Olympics will handle Covid outbreaks.

Chris Beyrer, MD, discusses countries lifting Covid restrictions, regional recovery from omicron in the U.S., and China’s vulnerability to Covid-19 as the Olympic games begin. 

Chris Beyrer, MD, discusses the state of the pandemic and Omicron variant in South Africa, which is seeing a remarkable decline in daily COVID deaths and cases. 

Rupali Limaye, associate professor of International Health, discusses the fight against growing antimicrobial resistance, infections that don’t respond to drugs.

Chris Beyrer discusses the easing of Covid curbs in the U.K. and continued omicron risk in the U.S.

Andy Pekosz, professor of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, discusses that vaccinated people who have been infected with the omicron variant may end up with a very high level of immunity that recognizes other variants. 

Chris Beyrer, epidemiologist at the Bloomberg School, says COVID may look “really different" in 6-8 weeks after omicron peaks.
 

Chris Beyrer, MD, discusses Covid-19 messaging and concerns about PCR testing and the availability of rapid testing.